Real Estate Pune
Jubilant Pharmova Reports 49% Surge in Profit After Tax to Rs 103 Crore
Jubilant Pharmova, a leading pharmaceutical company, has reported a significant 49% increase in profit after tax (PAT) to Rs 103 crore for the first quarter ended June 30, 2025. This marks a robust performance, driven by consistent revenue growth across all business units.
Real Estate
Markets Gain Momentum as Realty and Pharma Stocks Boost Sentiment
Godrej Properties launches a high-end residential project in Bengaluru, while Biocon Ltd receives positive feedback from the USFDA. These developments, along with other positive corporate news, are driving the market sentiment higher.
Real Estate
Leena Tewari's ₹703 Crore Duplex Sets New Record in Mumbai's Luxury Real Estate
Leena Gandhi Tewari, chairperson of pharmaceutical giant USV, has purchased two ultra-luxury, sea-facing duplex apartments in Mumbai’s upscale Worli area for a staggering ₹703 crore, setting a new national record.
Real Estate Mumbai
Mumbai's ₹639 Crore Property Deal: Pharma Tycoons Invest in Luxury Flats
Pharmaceutical firm USV's chairperson, Leena Gandhi Tewari, buys two luxury sea-facing duplex apartments in Mumbai’s posh Worli area for ₹639 crore. Explore why pharma tycoons are driving the luxury real estate market.
Real Estate
India's Pharmaceutical Industry Gains Global Ground Amid US-China Tensions
Indian pharmaceutical firms are making strategic international acquisitions and investing in advanced drug development, capitalizing on the global push for nearshoring and diversification away from China.
Real Estate
Top 2 Stocks to Buy for a Potential Upside of 13%: TradeBrains Portal Recommendations
In this article, we explore two promising stocks from the pharmaceutical and real estate sectors, recommended by the TradeBrains Portal, with an upside potential of up to 13%. We also provide an analysis of their performance and market trends.